Preclinical Oncology Services Ltd. (PRECOS) has extended its alliance with Argenta for comprehensive oncology-focused drug discovery services. The five-year extension will allow both companies to continue to offer expertise in cancer research to their pharmaceutical clients. PRECOS offers advanced patient-relevant in vivo models that closely reflect the clinical situation for each aspect of cancer progression, encompassing pre-cancerous lesions, primary tumors and metastasis. This ability to ...